Thank you, Dan. Good morning, everyone. Starting with Slide 4, you will see our recent strategic land acquisition in Arvada, Colorado. The aerial shot on the right of the slide shows our current campus, with bold black outlines marking our existing footprint. To the right of that is the new plot of land we have secured. As you can see, the image highlights the space constraints we have been working within. This $1.4 million investment is a proactive step to address those limitations as we continue to grow. This new plot will enable us to consolidate certain operations, freeing up space within our existing facilities and better positioning us for future expansion. With the construction slated to begin in fiscal year 2026, the additional facility will support our long-term growth initiatives, allowing us to scale for new product lines and smaller emerging programs as we move forward. Moving to Slide 5, as announced in our release yesterday, we are excited to share plans for a state-of-the-art cryogenic propellant testing facility, set to be constructed near our P3 Technologies subsidiary in Florida. By providing a scalable, cost-effective alternative to existing centers, which often prioritize flagstaff programs, our facility will serve critical programs needing timely, specialized testing solutions for liquid hydrogen, liquid oxygen and liquid methane across space, defense, new energy, and potentially even medical applications. Enhanced capabilities will include in-house product validation for quality assurance, covering testing for pumps, components, fluid management systems and combustion devices. The facility will also enable us to enter high -- new high-demanding markets with scalable testing solutions, addressing the involving needs for customers across all of our segments. Additionally, it will support early feasibility studies for potential long-term customers, making this a versatile asset that aligns with our strategic goals. We are aiming to break ground soon and expect initial testing to begin by mid-calendar year 2025. Financially, the facility is projected to achieve a cash payback in approximately two years to three years and deliver an internal rate of return exceeding 20%. To summarize, these two initiatives, the land acquisition in Colorado and the new testing facility in Florida, are crucial steps in preparing for the future, providing the space and capabilities needed to support both current growth and future innovation. We are excited to leverage these investments as we continue to expand our reach in critical markets. With that, I will turn it over to Chris for second quarter financial details. Chris?